Advances in Clinical and Experimental Medicine

Adv Clin Exp Med
Impact Factor (IF) – 1.227
Index Copernicus (ICV 2018) – 157.72
MNiSW – 40
Average rejection rate – 84.38%
ISSN 1899–5276 (print)
ISSN 2451-2680 (online)
Periodicity – monthly

Download PDF

Advances in Clinical and Experimental Medicine

2019, vol. 28, nr 8, August, p. 1087–1094

doi: 10.17219/acem/104538

Publication type: original article

Language: English

Download citation:

  • BIBTEX (JabRef, Mendeley)
  • RIS (Papers, Reference Manager, RefWorks, Zotero)

Creative Commons BY-NC-ND 3.0 Open Access

Genetic polymorphisms in pattern recognition receptors are associated with allergic diseases through gene–gene interactions

Anna Dębińska1,A,B,C,D,E, Hanna Danielewicz1,A,C,E, Anna Drabik-Chamerska1,B,C, Danuta Kalita1,B,C, Andrzej Boznański1,A,E,F

1 1st Department and Clinic of Pediatrics, Allergology and Cardiology, Wroclaw Medical University, Poland


Background. There is evidence that suggests variation in gene encoding pattern recognition receptors, the essential components of innate immunity, might be associated with atopic diseases. However, results have been inconclusive.
Objectives. The aim of the study was to determine the individual associations and possible interactive effects of the CD14 (cluster of differentiation 14), TLR4 (toll-like receptor 4) and TLR2 (toll-like receptor 2) polymorphisms on allergic diseases.
Material and Methods. The CD14 C-159T, TLR4 +896A/G and TLR2 A-16934T polymorphisms were identified in 115 children aged from 6 to 17 years. All subjects were selected using a detailed questionnaire which included questions on symptoms and each one underwent skin prick testing. All single-nucleotide polymorphisms (SNPs) were determined using real-time polymerase chain reaction (PCR) assays.
Results. There was no statistically significant correlation between the 3 polymorphisms (CD14 C-159T, TLR4 +896A/G and TLR2/-16934A/T) and either asthma, allergic rhinitis or atopy. We observed that children who were heterozygous or homozygous for both the CD14/-159T and TLR2/-16934A alleles had a 4-fold lower risk for asthma than children who were carriers of the T allele of CD14 but non-carriers of the A allele of TLR2, and an almost 3-fold lower risk for asthma when compared to all other groups. Concerning allergic rhinitis, a similar trend was observed. In addition, the presence of at least 1 A allele in the TLR2/-16934 polymorphism reduced the risk for asthma and allergic rhinitis, but only in children who were homozygous for the common A allele in the TLR4 +896 polymorphism.
Conclusion. Our study supports the idea that the CD14, TLR2 and TLR4 polymorphisms may not be directly involved in the development of atopic diseases. However, our results suggest that their impact on the risk of asthma and allergic rhinitis might be modulated by gene–gene interactions.

Key words

single nucleotide polymorphisms, asthma, innate immunity, atopy, gene–gene interactions

References (50)

  1. Arancibia SA, Beltrán CJ, Aguirre IM, et al. Toll-like receptors are key participants in innate immune responses. Biol Res. 2007;40(2):97–112.
  2. Iwamura C, Nakayama T. Toll-like receptors in the respiratory system: Their roles in inflammation. Curr Allergy Asthma Rep. 2008;8(1):7–13.
  3. Bauer S, Hangel D, Yu P. Immunobiology of toll-like receptor in allergic disease. Immunobiology. 2007;212(6):521–533.
  4. Goldman M. Translational mini-review series on Toll-like receptors: Toll-like receptor ligands as novel pharmaceuticals for allergic disorders. Clin Exp Immunol. 2007;147(2):208–216.
  5. Liu G, Zhang L, Zhao Y. Modulation of immune responses through direct activation of toll-like receptors to T cells. Clin Exp Immunol. 2010;160(2):168–175.
  6. Garn H, Renz H. Epidemiological and immunological evidence for hygiene hypothesis. Immunobiology. 2007;212(6):441–452.
  7. von Mutius E. Allergies, infection and the hygiene hypothesis: The epidemiological evidence. Immunobiology. 2007;212(6):433–439.
  8. Tesse R, Pandey RC, Kabesch M. Genetic variations in toll-like receptor pathway genes influence asthma and atopy. Allergy. 2011;66(3):307–316.
  9. Dalvi MS, Halonen MA. A polymorphism in TLR2 (−16934A/T) influences TLR2 surface expression on human monocytes. Proc Am ­Thorac Soc. 2005;2:A736.
  10. Arbour NC, Lorenz E, Schutte BC, et al. TLR4 mutation are associated with endotoxin hyporesponsiveness in humans. Nat Genet. 2000;25(2):187–191.
  11. LeVan TD, Bloom JW, Bailey TJ, et al. A common single nucleotide polymorphism in the CD14 promoter decreases the affinity of Sp protein binding and enhances transcriptional activity. J Immunol. 2001;167(10):5838–5844.
  12. Kaisho T, Akira S. Toll-like receptor function and signaling. J Allergy Clin Immunol. 2006;117(5):979–987.
  13. Michel O, LeVan TD, Stern D, et al. Systemic responsiveness to lipopolysaccharide and polymorphisms in the toll-like receptor 4 gene in human beings. J Allergy Clin Immunol. 2003;112(5):923–929.
  14. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science. 1990;249(4975):1431–1433.
  15. Postma DS, Bleecker ER, Amelung PJ, et al. Genetic susceptibility to asthma-bronchial hyperresponsiveness co-inherited with a major gene for atopy. N Engl J Med. 1995;333(14):894–900.
  16. LeVan TD, Michel O, Dentener M, et al. Association between CD14 polymorphisms and serum soluble CD14 levels: Effect of atopy and endotoxin inhalation. J Allergy Clin Immunol. 2008;121(2):434–440.
  17. Baldini M, Lohman IC, Halonen M, Erickson RP, Holt PG, Martinez FD. A polymorphism in the 5’ flanking region of the CD14 gene is associated with circulating soluble CD14 levels and with total serum immunoglobulin E. Am J Respir Cell Mol Biol. 1999;20(5):976–983.
  18. Koppelman GH, Reijmerink NE, Colin Stine O, et al. Association of a promoter polymorphism of the CD14 gene and atopy. Am J Respir Crit Care Med. 2001;163(4):965–969.
  19. Leung TF, Tang NL, Sung YM, et al. The C-159T polymorphism in the CD14 promoter is associated with serum total IgE concentration in atopic Chinese children. Pediatr Allergy Immunol. 2003;14(4):255–260.
  20. Sackensen C, Karaaslan C, Keskin O, et al. The effect of polymorphisms at the CD14 promoter and the TLR4 gene on asthma phenotypes in Turkish children with asthma. Allergy. 2005;60(12):1485–1492.
  21. Kabesch M, Hasemann K, Schickinger V, et al. A promoter polymorphism in the CD14 gene is associated with elevated levels of soluble CD14 but not with IgE or atopic diseases. Allergy. 2004;59(5):520–525.
  22. Klaassen EM, Thönissen BE, van Eys G, Dompeling E, Jöbsis Q. A systemic review of CD14 and toll-like receptors in relation to asthma in Caucasian children. Allergy Asthma Clin Immunol. 2013;9(1):10.
  23. Zhao J, Shang H, Cao X, et al. Associations in polymorphisms in TLR2 and TLR4 with asthma risk. Medicine (Baltimore). 2017;96(35):e7909.
  24. Tizaoui K, Kaabachi W, Hamzaoui K, Hamzaoui A. Association in single nucleotide polymorphisms in Toll-like receptor genes with asthma risk: A systemic review and meta-analysis. Allergy Asthma Immunol Res. 2015;7(2):130–140.
  25. Zhao L, Bracken MB. Association of CD14 -260 (-159) C>T and asthma: A systematic review and meta-analysis. BMC Med Genet. 2011;12:93–103.
  26. Eder W, Klimecki W, Lizhi Y, et al; ALEX Study Team. Toll-like receptor 2 as a major genes for asthma in children of European farmers. J Allergy Clin Immunol. 2004;113(3):482–488.
  27. Fagerås Böttcher M, Hmani-Aifa M, Lindström A, et al. A TLR4 polymorphism is associated with asthma and reduction lipopolysaccharide-induced interleukin-12 (p70) responses in Swedish children. J Allergy Clin Immunol. 2004;114(3):561–567.
  28. Yang IA, Barton SJ, Rorke S, et al. Toll-like receptor 4 polymorphism and severity of atopy in asthmatics. Genes Immun. 2004;5(1):41–45.
  29. Raby BA, Klimecki WT, Laprise C, et al. Polymorphisms in Toll-like receptor 4 are not associated with asthma or atopy-related phenotypes. Am J Respir Crit Care Med. 2002;166(11):1449–1456.
  30. Smit LAM, Bongers SIM, Ruven HJT, et al. Atopy and new-onset asthma in young Danish farmers and CD14, TLR2 and TLR4 genetic polymorphisms: A nested case-control study. Clin Exp Allergy. 2007;37(11):1602–1608.
  31. Lachheb J, Dhifallah IB, Chelbi H, Hamzaoui K, Hamzaoui A. Toll-like receptors and CD14 genes polymorphisms and susceptibility to asthma in Tunisian children. Tissue Antigens. 2008;71(5):417–425.
  32. Han D, She W, Zhang L. Association of the CD14 gene polymorphism C-159T with allergic rhinitis. Am J Rhinol Allergy. 2010;24(1):e1–3.
  33. Woo JG, Assa’ad A, Heizer AB, et al. The -159 C-->T polymorphism of CD14 is associated with nonatopic asthma and food allergy. J Allergy Clin Immunol. 2003;112:438–444.
  34. Bateman ED, Hurd SS, Barnes PJ, et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J. 2008;31(1):143–178.
  35. Kowal K, Bodzenta-Lukaszyk A, Pampuch A, et al. Analysis of -675 4 g/5G SERPINE1 and C-159T CD14 polymorphisms in house dust mite-allergic asthma patients. J Investig Allergol Clin Immunol. 2008;18(4):284–292.
  36. Lis G, Kostyk E, Sanak M, Pietrzyk JJ. Badania molekularne w populacji dzieci chorych na astmę oskrzelową. Cz.I. Polimorfizm regionu promotorowego genu CD14. Pneumonol Alergol Pol. 2001;69(5–6):265–272.
  37. Zabrowski T, Wojas-Krawczyk K, Krawczyk P, et al. The effect of CD14 and TLR4 gene polymorphisms on the occurrence of atopic and non-atopic asthma. Adv Clin Exp Med. 2011;20(4):413–421.
  38. Rennie DC, Karunanayake CP, Chen Y, et al. CD14 gene variants and their importance for childhood croup, atopy and asthma. Dis ­Markers. 2013;35(6):765–771.
  39. Sengler C, Haider A, Sommerfeld C, et al; German Multicenter Allergy Study Group. Evaluation of the CD14 C-159T polymorphism in the German Multicenter Allergy Study cohort. Clin Exp Allergy. 2003;33(2):166–169.
  40. Liang XH, Cheung W, Heng CK, et al. CD14 promoter polymorphisms have no functional significance and are not associated with atopic phenotypes. Pharmacogenet Genomics. 2006;16(4):229–236.
  41. Nishimura F, Shibasaki M, Ichikawa K, Arinami T, Noguchi E. Failure to find an association between CD14-159C/T polymorphism and asthma: A family-based association test and meta-analysis. Allergol Int. 2006;55(1):55–58.
  42. Ortiz-Martinez MG, Frias-Belen O, Nazario-Jimenes S, et al. A case-control study of innate immunity pathway gene polymorphisms in Puerto Ricans reveals association of toll-like receptor 2 +596 variant with asthma. BMC Pulm Med. 2016;16:112–122.
  43. Zambelli-Weiner A, Ehrlich E, Stockton ML, et al. Evaluation of the CD14/-260 polymorphism and house dust endotoxin exposure in the Barbados Asthma Genetics Study. J Allergy Clin Immunol. 2005;115(6):1203–1209.
  44. De Faria ICJ, de Faria EJ, Toro AADC Ribeiro JD, Bertuzzo CS. Association for TGF-β1, CD14, IL-4, IL-4R and ADAM33 gene polymorphisms with asthma severity in children and adolescents. J Pediatr (Rio J). 2008;84(3):203–210.
  45. Hussein YM, Hanan AA, Shalaby SM, Ali AA, Alzahrani SS. Toll-like receptor 2 and Toll-like receptor 4 polymorphisms and susceptibility to asthma and allergic rhinitis: A case-control analysis. Cell Immunol. 2012;274(1–2):34–38.
  46. Kang I, Oh YK, Lee SH, Jung HM, Chae SC, Lee JH. Identification of polymorphisms in the Toll-like receptor gene and the association with allergic rhinitis. Eur Arch Otorhinolaryngol. 2010;267(3):385–389.
  47. Noguchi E, Nishimura F, Fukai H, et al. An association study of asthma and total serum immunoglobulin E levels for Toll-like receptor polymorphisms in Japanese population. Clin Exp Allergy. 2004;34(2):177–183.
  48. Kerkhof M, Postma DS, Brunekreef B, et al. Toll-like receptor 2 and 4 genes influence susceptibility to adverse effects of traffic-related air pollution on childhood asthma. Thorax. 2010;65(8):690–697.
  49. Reijmerink NE, Bottema RWB, Kerkhof M, et al. TLR-related pathway analysis: Novel gene-gene interaction in the development of asthma and atopy. Allergy. 2010;65(2):199–207.
  50. Bottema RWB, Kerkhof M, Reijmerink NE, et al. Gene-gene interaction in regulatory T-cell function in atopy and asthma development in childhood. J Allergy Clin Immunol. 2010;126(2):338–344.